Dina Nair Selected Research

Lymph Node Tuberculosis (Scrofula)

1/2020	Filarial Coinfection Is Associated With Higher Bacterial Burdens and Altered Plasma Cytokine and Chemokine Responses in Tuberculous Lymphadenitis.
1/2018	Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
5/2017	Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1β (IL-1β) and IL-18 at the Site of Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dina Nair Research Topics

Disease

19	Pulmonary Tuberculosis 11/2021 - 01/2014
12	Tuberculosis (Tuberculoses) 11/2021 - 09/2015
7	Infections 01/2020 - 01/2014
4	Latent Tuberculosis 01/2020 - 12/2015
4	Type 2 Diabetes Mellitus (MODY) 03/2016 - 01/2014
3	Coinfection 01/2020 - 12/2015
3	Lymph Node Tuberculosis (Scrofula) 01/2020 - 05/2017
1	Extrapulmonary Tuberculosis 01/2020
1	Inflammation (Inflammations) 03/2016
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2016
1	Necrosis 04/2015

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 01/2020 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2016
4	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 01/2014
3	Moxifloxacin (Avelox)FDA Link 01/2020 - 11/2014
2	ChemokinesIBA 11/2021 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 09/2015
2	Interleukin-2 (IL2)IBA 01/2020 - 01/2017
2	AdipokinesIBA 10/2018 - 03/2016
2	interleukin 20 (IL-20)IBA 01/2018 - 12/2015
2	AntigensIBA 05/2017 - 04/2015
1	Pharmaceutical PreparationsIBA 11/2021
1	Interleukin-12 (IL 12)IBA 01/2020
1	CXC ChemokinesIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	ResistinIBA 10/2018
1	LeptinIBA 10/2018
1	AdiponectinIBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	IronIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Interleukin-18 (Interleukin 18)IBA 05/2017
1	Interleukin-7 (Interleukin 7)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	interleukin-21 (interleukin 21)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Vascular Endothelial Growth Factor CIBA 01/2016
1	Vascular Endothelial Growth Factor DIBA 01/2016
1	Interleukin-27 (Interleukin 27)IBA 09/2015
1	Isoniazid (Ftivazide)FDA LinkGeneric 11/2014
1	Pyrazinamide FDA LinkGeneric 11/2014
1	Ethambutol (Myambutol)FDA LinkGeneric 11/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 11/2014
1	Lipopolysaccharide ReceptorsIBA 01/2014
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2018 - 05/2017
1	Duration of Therapy 01/2020
1	Therapeutics 01/2020
1	Time-to-Treatment 01/2016